I agree pravda......cash from an infringement/license campaign carries little if any multiple. Investors invest in product or services that generate revenue and double digit revenue growth......that's what will bring a multiple.

Having been in EDIG and PTSC for 10+ years it is painfully obvious with PTSC that licensing alone won't do it. Then when they tried to buy their way into product lines they seem to have failed at that........along with CEO's who haven't worked out.

Even with loads of cash there is much room for error. Maybe Woody should help us?!?

Biomedman